Kocak Zafer, Borst Gerben R, Zeng Jing, Zhou Sumin, Hollis Donna R, Zhang Junan, Evans Elizabeth S, Folz Rodney J, Wong Terrence, Kahn Daniel, Belderbos Jose S A, Lebesque Joos V, Marks Lawrence B
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):178-86. doi: 10.1016/j.ijrobp.2006.09.031.
Clinical and 3D dosimetric parameters are associated with symptomatic radiation pneumonitis rates in retrospective studies. Such parameters include: mean lung dose (MLD), radiation (RT) dose to perfused lung (via SPECT), and pre-RT lung function. Based on prior publications, we defined pre-RT criteria hypothesized to be predictive for later development of pneumonitis. We herein prospectively test the predictive abilities of these dosimetric/functional parameters on 2 cohorts of patients from Duke and The Netherlands Cancer Institute (NKI).
For the Duke cohort, 55 eligible patients treated between 1999 and 2005 on a prospective IRB-approved study to monitor RT-induced lung injury were analyzed. A similar group of patients treated at the NKI between 1996 and 2002 were identified. Patients believed to be at high and low risk for pneumonitis were defined based on: (1) MLD; (2) OpRP (sum of predicted perfusion reduction based on regional dose-response curve); and (3) pre-RT DLCO. All doses reflected tissue density heterogeneity. The rates of grade > or =2 pneumonitis in the "presumed" high and low risk groups were compared using Fisher's exact test.
In the Duke group, pneumonitis rates in patients prospectively deemed to be at "high" vs. "low" risk are 7 of 20 and 9 of 35, respectively; p = 0.33 one-tailed Fisher's. Similarly, comparable rates for the NKI group are 4 of 21 and 6 of 44, respectively, p = 0.41 one-tailed Fisher's.
The prospective model appears unable to accurately segregate patients into high vs. low risk groups. However, considered retrospectively, these data are consistent with prior studies suggesting that dosimetric (e.g., MLD) and functional (e.g., PFTs or SPECT) parameters are predictive for RT-induced pneumonitis. Additional work is needed to better identify, and prospectively assess, predictors of RT-induced lung injury.
在回顾性研究中,临床和三维剂量学参数与放射性肺炎的症状发生率相关。这些参数包括:平均肺剂量(MLD)、灌注肺的放射剂量(通过单光子发射计算机断层扫描)以及放疗前的肺功能。基于先前的出版物,我们定义了放疗前的标准,推测这些标准可预测肺炎的后期发展。我们在此前瞻性地测试这些剂量学/功能参数对来自杜克大学和荷兰癌症研究所(NKI)的两组患者的预测能力。
对于杜克大学队列,分析了1999年至2005年期间在一项前瞻性IRB批准的研究中接受治疗以监测放疗引起的肺损伤的55例合格患者。确定了1996年至2002年期间在NKI接受治疗的一组类似患者。根据以下因素将被认为肺炎高风险和低风险的患者进行定义:(1)平均肺剂量;(2)OpRP(基于区域剂量反应曲线预测的灌注减少总和);(3)放疗前的一氧化碳弥散量(DLCO)。所有剂量均反映了组织密度异质性。使用Fisher精确检验比较“假定”的高风险和低风险组中≥2级肺炎的发生率。
在杜克大学组中,前瞻性地被认为处于“高”风险与“低”风险的患者中肺炎发生率分别为20例中的7例和35例中的9例;单尾Fisher检验p = 0.33。同样,NKI组的可比发生率分别为21例中的4例和44例中的6例,单尾Fisher检验p = 0.41。
前瞻性模型似乎无法准确地将患者分为高风险组和低风险组。然而,回顾性考虑,这些数据与先前的研究一致,表明剂量学(例如平均肺剂量)和功能(例如肺功能测试或单光子发射计算机断层扫描)参数可预测放疗引起的肺炎。需要进一步开展工作以更好地识别并前瞻性评估放疗引起的肺损伤的预测因素。